Prashant R. Murumkar

Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis

Rupesh V. Chikhale, Mahesh A. Barmade, Prashant R. Murumkar et al. · Journal of Medicinal Chemistry · 2018 · 140 citations · Full text

Drug Library, Tuberculosis Prevention, Immunology +18

Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer’s Agents: Synthesis and Biological Evaluation

Mahesh Mohan Shidore, Jatin Machhi, Kaushik Shingala et al. · Journal of Medicinal Chemistry · 2016 · 107 citations · Full text

Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors

Titiksh L. Devale, Jignesh Parikh, Pankaj B. Miniyar et al. · Bioorganic Chemistry · 2017 · 52 citations · Full text

Medicine, Antiviral Drug Development, Resistance Mutation (Virology) +5

Development of predictive pharmacophore model for in silico screening, and 3D QSAR CoMFA and CoMSIA studies for lead optimization, for designing of potent tumor necrosis factor alpha converting enzyme inhibitors

Prashant R. Murumkar, Vishal P. Zambre, Mange Ram Yadav · Journal of Computer-Aided Molecular Design · 2010 · 45 citations

Medicinal Chemistry, Drug Target, Biochemistry +12

Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents

Dushyant V. Patel, Nirav R. Patel, Ashish M. Kanhed et al. · ACS Chemical Neuroscience · 2019 · 42 citations